D. N. Louis, A. Perry, G. Reifenberger, A. Von-deimling, and D. Figarella-branger, , p.19

W. K. Cavenee, H. Ohgaki, O. D. Wiestler, P. Kleihues, and D. W. Ellison, , 2016.

, Health Organization Classification of Tumors of the Central Nervous System: A Summary. Acta 21 Neuropathol, vol.131, pp.803-823, 2016.

R. Stupp, M. E. Hegi, W. P. Mason, M. J. Van-den-bent, M. J. Taphoorn et al., , vol.24

C. Marosi, C. J. Vecht, K. Mokhtari, P. Wesseling, S. Villa et al., , vol.25

M. Weller, D. Lacombe, J. G. Cairncross, and R. O. Mirimanoff, European Organisation for, R.; 26 Treatment of Cancer Brain, T.; Radiation Oncology, G.; National Cancer Institute of Canada 27 Clinical Trials, Effects of Radiotherapy with Concomitant and Adjuvant Temozolomide, p.28

, Versus Radiotherapy Alone on Survival in Glioblastoma in a Randomised Phase Iii Study: 51 Year Analysis of the Eortc-Ncic Trial, Lancet Oncol, vol.10, pp.459-66, 2009.

A. A. Thomas, C. W. Brennan, L. M. Deangelis, and A. M. Omuro, Emerging Therapies 3 for Glioblastoma, JAMA neurology, vol.71, pp.1437-1481, 2014.

M. G. Netsky, B. August, and W. Fowler, The Longevity of Patients with Glioblastoma 5

. J. Multiforme and . Neurosurg, , vol.7, pp.261-270, 1950.

D. Peer, J. M. Karp, S. Hong, O. C. Farokhzad, R. Margalit et al., Nanocarriers 7 as an Emerging Platform for Cancer Therapy, Nat. Nanotechnol, vol.2, pp.751-760, 2007.

A. Bernardi, E. Braganhol, E. Jager, F. Figueiro, M. I. Edelweiss et al., , vol.9

S. S. Guterres and A. M. Battastini, Indomethacin-Loaded Nanocapsules Treatment Reduces in 10 Vivo Glioblastoma Growth in a Rat Glioma Model, Cancer Lett, vol.281, pp.53-63, 2009.

N. T. Huynh, C. Passirani, P. Saulnier, and J. P. Benoit, Lipid Nanocapsules: A New 12 Platform for Nanomedicine, Int. J. Pharm, vol.379, pp.201-210, 2009.

O. Thomas and F. Lagarce, Lipid Nanocapsules: A Nanocarrier Suitable for Scale-up 14 Process, J. Drug Delivery Sci. Technol, vol.23, pp.555-559, 2013.

E. Allard, N. T. Huynh, A. Vessieres, P. Pigeon, G. Jaouen et al., , p.16

C. , Dose Effect Activity of Ferrocifen-Loaded Lipid Nanocapsules on a 9l-Glioma Model, Int. J. 17 Pharm, vol.379, p.10, 2009.

M. Roger, A. Clavreul, N. T. Huynh, C. Passirani, P. Schiller et al.,

C. Menei and P. Menei, Ferrociphenol Lipid Nanocapsule Delivery by Mesenchymal Stromal Cells 20 in Brain Tumor Therapy, Int. J. Pharm, vol.423, p.11, 2012.

A. Zanotto-filho, K. Coradini, E. Braganhol, R. Schroder, and C. M. De-oliveira,

A. Pires, A. M. Battastini, A. R. Pohlmann, S. S. Guterres, C. M. Forcelini et al., , p.23

J. C. Moreira, Curcumin-Loaded Lipid-Core Nanocapsules as a Strategy to Improve 24 Pharmacological Efficacy of Curcumin in Glioma Treatment, Eur. J. Pharm. Biopharm, vol.25, p.12, 2013.

Y. Wang, P. Pigeon, S. Top, M. J. Mcglinchey, and G. Jaouen, Organometallic Antitumor 27 Compounds: Ferrocifens as Precursors to Quinone Methides, Angew. Chem. Int. Ed. Engl, vol.28, p.13, 2015.

G. Jaouen, P. Pigeon, and S. Top, Metallocene Derivatives with Anticancer Activity. 30 WO2015063201 (A1), vol.31, 2015.

Y. Yang, Z. Yan, D. Wei, J. Zhong, L. Liu et al., , p.32

W. Lu and D. He, Tumor-Penetrating Peptide Functionalization Enhances the Anti-Glioblastoma 33 Effect of Doxorubicin Liposomes, Nanotechnology, vol.24, p.15, 2013.

G. Liu, H. Shen, J. Mao, L. Zhang, Z. Jiang et al., Transferrin 35 Modified Graphene Oxide for Glioma-Targeted Drug Delivery: In Vitro and in Vivo 36 Evaluations, ACS Appl Mater Interfaces, vol.5, p.16, 2013.

Y. Fu, N. An, K. Li, Y. Zheng, and A. Liang, Chlorotoxin-Conjugated Nanoparticles as 38 Potential Glioma-Targeted Drugs, J. Neurooncol, vol.107, p.17, 2012.

X. Wei, J. Gao, C. Zhan, C. Xie, Z. Chai et al., , p.40

, Liposome-Based Glioma Targeted Drug Delivery Enabled by Stable Peptide Ligands, J. Control, vol.41, pp.13-21, 2015.

R. Berges, J. Balzeau, A. C. Peterson, and J. Eyer, A Tubulin Binding Peptide Targets 43

, Glioma Cells Disrupting Their Microtubules, Blocking Migration, and Inducing Apoptosis

. Ther, , vol.20, pp.1367-77, 2012.

J. Balzeau, M. Pinier, R. Berges, P. Saulnier, J. P. Benoit et al., The Effect of 1

, Functionalizing Lipid Nanocapsules with Nfl-Tbs.40-63 Peptide on Their Uptake by 2 Glioblastoma Cells, Biomaterials, vol.34, pp.3381-3390, 2013.

A. L. Laine, N. T. Huynh, A. Clavreul, J. Balzeau, J. Bejaud et al.,

P. Eyer, J. Passirani, and C. , Brain Tumour Targeting Strategies Via Coated Ferrociphenol Lipid 5 Nanocapsules, Eur. J. Pharm. Biopharm, vol.81, p.21, 2012.

B. Heurtault, P. Saulnier, B. Pech, J. E. Proust, and J. P. Benoit, A Novel Phase Inversion7

, Based Process for the Preparation of Lipid Nanocarriers, Pharm. Res, vol.19, p.22, 2002.

D. Carradori, P. Saulnier, V. Preat, A. Des-rieux, and J. Eyer, Nfl-Lipid Nanocapsules for 9

, Brain Neural Stem Cell Targeting in Vitro and in Vivo, J. Control. Release, vol.238, p.23, 2016.

C. Lepinoux-chambaud and J. Eyer, The Nfl-Tbs.40-63 Anti-Glioblastoma Peptide Enters 11 Selectively in Glioma Cells by Endocytosis, Int. J. Pharm, vol.454, p.24, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01412546

N. T. Huynh, C. Passirani, E. Allard-vannier, L. Lemaire, J. Roux et al., Administration-Dependent Efficacy of Ferrociphenol Lipid 14 Nanocapsules for the Treatment of Intracranial 9l Rat Gliosarcoma, Int. J. Pharm, vol.13, p.25, 2012.

E. Allard, D. Jarnet, A. Vessieres, S. Vinchon-petit, G. Jaouen et al., Local Delivery of Ferrociphenol Lipid Nanocapsules Followed by External 18

, Radiotherapy as a Synergistic Treatment against Intracranial 9l Glioma Xenograft, Pharm. Res, vol.27, p.26, 2010.

C. P. Haar, P. Hebbar, G. C. Wallace, A. Das, W. A. Vandergrift et al., , vol.21

P. Giglio, S. J. Patel, S. K. Ray, and N. L. Banik, Drug Resistance in Glioblastoma: A Mini 22 Review, Neurochem. Res, vol.37, p.27, 2012.

R. M. Straubinger, A. Sharma, M. Murray, and E. Mayhew, Novel Taxol Formulations: 24 Taxol-Containing Liposomes, J. Natl. Cancer Inst, vol.25, p.28, 1993.

R. Berges, J. Balzeau, M. Takahashi, C. Prevost, and J. Eyer, Structure-Function Analysis 26 of the Glioma Targeting Nfl-Tbs.40-63 Peptide Corresponding to the Tubulin-Binding Site on 27 the Light Neurofilament Subunit, PLoS One, vol.7, p.29, 2012.

E. Allard, C. Passirani, and J. P. Benoit, Convection-Enhanced Delivery of Nanocarriers for 29 the Treatment of Brain Tumors, Biomaterials, vol.30, pp.2302-2320, 2009.

V. P. Torchilin, R. Rammohan, V. Weissig, and T. S. Levchenko, Tat Peptide on the 31 Surface of Liposomes Affords Their Efficient Intracellular Delivery Even at Low Temperature 32 and in the Presence of Metabolic Inhibitors, P. Natl. Acad. Sci, vol.98, p.31, 2001.

X. Yu and J. Zheng, Polymorphic Structures of Alzheimer's Beta-Amyloid Globulomers, PLoS One, vol.34, p.32, 2011.

M. Zhou, A. M. Smith, A. K. Das, N. W. Hodson, R. F. Collins et al., , p.36

J. E. , Self-Assembled Peptide-Based Hydrogels as Scaffolds for Anchorage-Dependent Cells, 37 Biomaterials, vol.30, p.33, 2009.

T. H. Larsen, M. C. Branco, K. Rajagopal, J. P. Schneider, and E. M. Furst, , p.39

, Dependent Gelation Kinetics of ?-Hairpin Peptide Hydrogels, Macromolecules, vol.42, p.34, 2009.

A. Vonarbourg, C. Passirani, P. Saulnier, P. Simard, J. C. Leroux et al., 42 Evaluation of Pegylated Lipid Nanocapsules Versus Complement System Activation, p.43

, Macrophage Uptake. J. Biomed. Mater. Res, vol.78, p.35, 2006.

A. Vonarbourg, C. Passirani, P. Saulnier, J. P. Benoit, H. Harashima et al., Parameters Influencing the 45 Stealthiness of Colloidal Drug Delivery Systems, Biomaterials, vol.27, p.1, 2006.

, Synergistic Effect between Size and Cholesterol Content in the Enhanced Hepatic Uptake 2 Clearance of Liposomes through Complement Activation in Rats, Pharm. Res, vol.13, p.37, 1996.

R. Karim, C. Palazzo, J. Laloy, A. S. Delvigne, S. Vanslambrouck et al., , vol.4

E. Lepeltier, F. Orange, J. M. Dogne, B. Evrard, C. Passirani et al., Development and 5 Evaluation of Injectable Nanosized Drug Delivery Systems for Apigenin, Int. J. Pharm, vol.6, p.38, 2017.

A. Paillard, F. Hindre, C. Vignes-colombeix, J. P. Benoit, and E. Garcion, The 8 Importance of Endo-Lysosomal Escape with Lipid Nanocapsules for Drug Subcellular 9 Bioavailability, Biomaterials, vol.31, p.39, 2010.

B. A. Avelar-freitas, V. G. Almeida, M. C. Pinto, F. A. Mourão, and A. Massensini,

R. Martins-filho, O. A. Rocha-vieira, E. Brito-melo, and G. E. , Trypan Blue Exclusion Assay 12 by Flow Cytometry. Braz, J. Med. Biol. Res, vol.47, p.40, 2014.

T. Patino, J. Soriano, L. Barrios, E. Ibanez, and C. Nogues, Surface Modification of 14

, Microparticles Causes Differential Uptake Responses in Normal and Tumoral Human Breast 15, Epithelial Cells. Sci. Rep, vol.5, p.41, 2015.

C. Lepinoux-chambaud, K. Barreau, and J. Eyer, The Neurofilament-Derived Peptide Nfl17

. Tbs, 40-63 Targets Neural Stem Cells and Affects Their Properties, Stem Cells Transl. Med, vol.18, p.42, 2016.

J. W. Patrick, R. C. Gamez, and D. H. Russell, The Influence of Lipid Bilayer 20

, Physicochemical Properties on Gramicidin a Conformer Preferences, Biophys. J, vol.110, p.43, 2016.

G. Sahay, D. Y. Alakhova, and A. V. Kabanov, Endocytosis of Nanomedicines, J. Control, vol.23, p.44, 2010.

A. Laine, A. Clavreul, A. Rousseau, C. Tétaud, A. Vessieres et al., , p.25

G. Aubert, L. Guilbert, M. Benoit, and J. , Inhibition of Ectopic Glioma Tumor Growth by a 26

, Potent Ferrocenyl Drug Loaded into Stealth Lipid Nanocapsules, Nanomedicine, vol.10, p.45, 2014.

R. Karim, S. Somani, M. Al-robaian, M. Mullin, R. Amor et al., , p.29

C. Bastiancich, K. Vanvarenberg, B. Ucakar, M. Pitorre, G. Bastiat et al., Tumor Regression after Intravenous Administration of Targeted Vesicles Entrapping the Vitamin 30 E ?-Tocotrienol, J. Control. Release, vol.246, p.47, 2016.

S. Cajot, N. Lautram, C. Passirani, and C. Jerome,

, Perspectives on Dual Targeting Delivery Systems for Brain Tumors. J. 37 Neuroimmune Pharmacol, J. Control. Release, vol.152, pp.6-16, 2011.